V

Versant Ventures

65 employees

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

Investor insights

Countries invested in

united states3

Sectors invested in

Health Care189
Biotechnology185
Medical88
Therapeutics76
Medical Device75
Pharmaceutical39
Health Diagnostics25
Life Science24
Biopharma21
Manufacturing19
Genetics17
Wellness12
Diabetes7
Interventional Pulmonology7
Pulmonology7
biotechnology6
oncology6
Immuno-Oncology6
Information Technology6
Hospital5

Funding rounds participated in

$1.5M sweet spot round size

Most of their 325 investments are in rounds between $12M and $45M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Health Care
Financial Services
Life Science opportunities
Medical Devices
Biopharmaceuticals
Company creation
Venture Capital

Date founded

1999

Investments made

T

Tentarix Biotherapeutics, Inc. raised $35M on September 6, 2023

Investors: Gilead Sciences, Amplitude Ventures, Samsara BioCapital and Versant Ventures

K

Kate Therapeutics raised $51M on June 8, 2023

Investors: UF Innovate | Ventures, Osage University Partners (OUP), Westlake Village BioPartners® and Versant Ventures

B

Belharra Therapeutics raised $50M on January 4, 2023

Investors: Versant Ventures

U

Undisclosed raised $30M on December 12, 2022

Investors: Black Diamond Therapeutics and Versant Ventures

i

iECURE, inc. raised $65M on November 30, 2022

Investors: LYFE Capital, OrbiMed Advisors, Novo Holdings and Versant Ventures

J

Jnana Therapeutics raised $107M on November 15, 2022

Investors: Avalon Venture, RA Capital Management, L.P., Polaris Partners and Versant Ventures

V

Vector BioPharma raised $30M on August 10, 2022

Investors: Versant Ventures

T

Tempest raised $15M on April 27, 2022

Investors: Versant Ventures

C

Cimeio Therapeutics raised $50M on April 13, 2022

Investors: Versant Ventures

V

Ventus Therapeutics raised $140M on February 9, 2022

Investors: Qatar Investment Authority, GV, RA Capital Management, L.P., Andreessen Horowitz, Casdin Capital, LLC, SoftBank Investment Advisers and Versant Ventures

FAQ